WallStreetZenWallStreetZen

NASDAQ: ZNTL
Zentalis Pharmaceuticals Inc Stock Ownership - Who owns Zentalis Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Zentalis Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Vincent VultaggioPAO and PFO2026-02-106,894$2.42
$16.70kSell
Vincent VultaggioPAO and PFO2026-02-093,379$2.39
$8.09kSell
Ingmar BrunsChief Medical Officer2026-02-09335$2.39
$801.66Sell
Julia Marie EastlandCEO President2026-02-09889$2.39
$2.13kSell
Vincent VultaggioPAO and PFO2026-02-0629,951$2.43
$72.78kSell
Julia Marie EastlandCEO President2026-02-067,866$2.43
$19.11kSell
Ingmar BrunsChief Medical Officer2026-02-062,962$2.43
$7.20kSell
Vincent VultaggioPAO and PFO2026-02-03556$2.52
$1.40kSell
Vincent VultaggioPAO and PFO2026-02-022,540$2.55
$6.48kSell
Walters Group10% Owner2025-12-316,459,973$1.20
$7.75MBuy

1 of 2

ZNTL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ZNTL insiders and whales buy or sell their stock.

ZNTL Shareholders

What type of owners hold Zentalis Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Walters Group9.76%7,050,000$19.11MInsider
Matrix Capital Management Company LP8.94%6,459,973$17.51MInsider
5am Venture Management LLC5.46%3,947,913$10.70MInstitution
Viking Global Investors LP5.46%3,943,284$10.69MInsider
David E. Goel5.29%3,821,739$10.36MInsider
Anthony Y. Sun5.23%3,780,043$10.24MInsider
Renaissance Technologies LLC3.99%2,883,745$7.81MInstitution
Vanguard Group Inc3.95%2,855,590$7.74MInstitution
Acadian Asset Management LLC3.94%2,849,294$7.72MInstitution
Citadel Advisors LLC2.72%1,964,255$5.32MInstitution

1 of 3

ZNTL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ZNTL56.18%42.88%Net SellingNet Buying
RNAC11.19%88.81%Net BuyingNet Selling
STRO26.82%73.18%Net BuyingNet Selling
ADAG5.24%0.00%
ABOS58.87%18.38%Net SellingNet Selling
View Top Biotech Stocks

Zentalis Pharmaceuticals Stock Ownership FAQ

Who owns Zentalis Pharmaceuticals?

Zentalis Pharmaceuticals (NASDAQ: ZNTL) is owned by 56.18% institutional shareholders, 42.88% Zentalis Pharmaceuticals insiders, and 0.94% retail investors. Walters Group is the largest individual Zentalis Pharmaceuticals shareholder, owning 7.05M shares representing 9.76% of the company. Walters Group's Zentalis Pharmaceuticals shares are currently valued at $19.11M.

If you're new to stock investing, here's how to buy Zentalis Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.